SARINAH BROWN: Open Payments
NPI 1346780145 · HANOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 24 payments from 7 companies in 2025. Trend: 2023 $726 · 2024 $669 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $211 |
| ABBVIE INC. | 7 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $28 |
| Corium, LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: AUSTEDO XR, VRAYLAR, CAPLYTA, INGREZZA, Azstarys, COBENFY, FANAPT.
Industry payments across MA — which companies pay providers there.
